Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Notable people
KEVIN TANG
Signature - Title
/s/ Kevin Tang - Manager
Location
San Diego, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TANG CAPITAL MANAGEMENT LLC.

Notify me when TANG CAPITAL MANAGEMENT LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ITOS ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $102,100 -$38,968,425 10,000 -99.7% TANG CAPITAL MANAGEMENT, LLC 29 Aug 2025
CRGX Cargo Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $44,700 -$13,631,846 10,000 -99.7% TANG CAPITAL MANAGEMENT, LLC 19 Aug 2025
ALLK Allakos Inc. Common Stock, par value $0.001 per share 100% $3,200 -$2,778,779 10,000 -99.9% TANG CAPITAL MANAGEMENT, LLC 15 May 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $60,117,785 $12,881,057 17,176,510 +27.3% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.9% $52,086,551 4,941,798 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share 9.9% $10,941,996 7,014,100 TANG CAPITAL MANAGEMENT, LLC 17 Jan 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 9.9% $6,208,827 8,223,612 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 9.9% $1,525,109 3,812,773 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.6% $7,382,395 5,859,044 TANG CAPITAL MANAGEMENT, LLC 03 Mar 2025
CYBN Cybin Inc. Common Stock, no par value 9.1% $10,504,757 $2,870,000 1,830,097 +37.6% TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
PMVP PMV Pharmaceuticals, Inc. Common Stock, par value $0.00001 per share 8.9% $6,702,907 4,720,357 TANG CAPITAL MANAGEMENT, LLC 16 Sep 2025
GLPG Galapagos NV Ordinary shares, no par value 8.4% $192,587,107 $22,486,521 5,559,674 +13.2% TANG CAPITAL MANAGEMENT, LLC 27 Oct 2025
DERM Journey Medical Corporation Common Stock, par value $0.0001 per share 8% $10,942,116 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
EOLS Evolus, Inc. Common Stock, par value $0.00001 per share 7.9% $47,675,186 4,997,399 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
KROS Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.9% $38,268,569 2,418,984 TANG CAPITAL MANAGEMENT, LLC 15 Oct 2025
AUPH Aurinia Pharmaceuticals Inc. Common Shares, no par value 7.3% $74,318,595 10,029,500 TANG CAPITAL MANAGEMENT, LLC 28 Feb 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 7% $22,131,324 $8,695,674 11,065,662 +64.7% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
DTIL Precision BioSciences, Inc. Common Stock, par value $0.000005 per share 6.4% $2,962,661 673,332 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.9% $113,976,225 2,454,797 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.3% $39,104,000 3,200,000 TANG CAPITAL MANAGEMENT, LLC 24 Apr 2025
IMCR Immunocore Holdings plc American Depositary Shares, each representing one ordinary share, nominal value GBP 0.002 per share 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share 5.2% $44,356,479 2,178,609 TANG CAPITAL MANAGEMENT, LLC 28 Mar 2025
CBIO Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 5.04% $8,785,000 700,000 TANG CAPITAL MANAGEMENT, LLC 02 Oct 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 5% $1,183,700 -$1,112,989 3,115,000 -48.5% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 4.8% $1,733,987 -$260,267 3,399,975 -13.1% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 3.5% $367,834 -$550,000 66,879 -59.9% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
OTLK Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share 3.4% $1,635,000 -$436,000 1,500,000 -21.1% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
HLVX HilleVax, Inc. Common Stock, par value $0.0001 per share 0% $0 -$10,135,200 0 -100% TANG CAPITAL MANAGEMENT, LLC 17 Sep 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share 0% $0 -$821,300 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
MNPR Monopar Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
SLRN Acelyrin, Inc. Common Stock, par value $0.00001 per share 0% $0 -$21,620,497 0 -100% TANG CAPITAL MANAGEMENT, LLC 21 May 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 0% $0 -$5,779,624 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025

Schedules 13D/G Reported by TANG CAPITAL MANAGEMENT LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.